Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe site’s revision/version indicator changed from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check20 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details content.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter revision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page update only shows a new revision number, changing from v3.4.1 to v3.4.2, with no observable changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 as part of a minor site maintenance; no changes to study data or page content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.